Secretory IgA as a diagnostic tool for Pseudomonas aeruginosa respiratory colonization

Journal of Cystic Fibrosis

Volumn 12, Issue 1, 2013, Pages 81-87

  Aanaes, Kasper ^a   Johansen, Helle Krogh ^a   Poulsen, Steen Seier ^b   Pressler, Tacjana ^a   Buchwald, Christian ^a   Høiby, Niels ^a,c  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Colonization; Cystic fibrosis; Diagnosis; IgA antibodies; Pseudomonas aeruginosa; Sinusitis

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; SECRETORY IMMUNOGLOBULIN;

ADULT; ANTIBODY DETECTION; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NOSE SECRETION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SALIVA LEVEL; SINUSITIS;

ADOLESCENT; BODY FLUIDS; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN A, SECRETORY; IMMUNOHISTOCHEMISTRY; MALE; NOSE; PSEUDOMONAS INFECTIONS; RESPIRATORY SYSTEM; SENSITIVITY AND SPECIFICITY; SPUTUM;

EID: 84870745042     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2012.07.001     Document Type: Article

References (33)

1. Bjarnsholt T., Jensen P.O., Fiandaca M.J., Pedersen J., Hansen C.R., Andersen C.B., et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol Jun 2009, 44(6):547-558.
2. Johansen H.K., Norregaard L., Gotzsche P.C., Pressler T., Koch C., Høiby N. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success?-A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection. Pediatr Pulmonol May 2004, 37(5):427-432.
3. Bryan L.E., Kureishi A., Rabin H.R. Detection of antibodies to Pseudomonas aeruginosa alginate extracellular polysaccharide in animals and cystic fibrosis patients by enzyme-linked immunosorbent assay. J Clin Microbiol Aug 1983, 18(2):276-282.
4. Pedersen S.S., Moller H., Espersen F., Sørensen C.H., Jensen T., Hoiby N. Mucosal immunity to Pseudomonas aeruginosa alginate in cystic fibrosis. APMIS Apr 1992, 100(4):326-334.
5. Johansen H.K., Høiby N. Local IgA and IgG response to intratracheal immunization with Pseudomonas aeruginosa antigens. APMIS Jan 1992, 100(1):87-90.
6. Johansen H.K., Aanaes K., Pressler T., Nielsen K.G., Fisker J., Skov M., et al. Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response. J Cyst Fibros May 15, 2012, [Epub ahead of print].
7. Pedersen S.S., Espersen F., Høiby N., Jensen T. Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis. J Clin Microbiol Apr 1990, 28(4):747-755.
8. Pressler T., Frederiksen B., Skov M., Garred P., Koch C., Høiby N. Early rise of anti-pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection-a case control study. J Cyst Fibros Jan 2006, 5(1):9-15.
9. Hansen S.K., Rau M.H., Johansen H.K., Ciofu O., Jelsbak L., Yang L., et al. Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection. ISME Jan 2012, 6(1):31-45.
10. Rasmussen J., Aanaes K., Norling R., Nielsen K.G., Johansen H.K., Buchwald C. CT of the paranasal sinuses is not a valid indicator for sinus surgery in CF patients. J Cyst Fibros Mar 2011, 11(2):93-99.
11. Holzmann D., Speich R., Kaufmann T., Laube I., Russi E.W., Simmen D., et al. Effects of sinus surgery in patients with cystic fibrosis after lung transplantation: a 10-year experience. Transplantation Jan 15, 2004, 77(1):134-136.
12. Vital D., Hofer M., Boehler A., Holzmann D. Posttransplant sinus surgery in lung transplant recipients with cystic fibrosis: a single institutional experience. Eur Arch Otorhinolaryngol Mar 30, 2012, [Epub ahead of print].
13. Walter S., Gudowius P., Bosshammer J., Romling U., Weissbrodt H., Schurmann W., et al. Epidemiology of chronic Pseudomonas aeruginosa infections in the airways of lung transplant recipients with cystic fibrosis. Thorax Apr 1997, 52(4):318-321.
14. Mainz J.G., Hentschel J., Schien C., Cramer N., Pfister W., Beck J.F., et al. Sinonasal persistence of Pseudomonas aeruginosa after lung transplantation. J Cyst Fibros Mar 2012, 11(2):158-161.
15. Frederiksen B., Koch C., Høiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol May 1997, 23(5):330-335.
16. Pressler T., Karpati F., Granstrom M., Knudsen P.K., Lindblad A., Hjelte L., et al. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods. J Cyst Fibros Jan 2009, 8(1):37-42.
17. Ratjen F., Walter H., Haug M., Meisner C., Grasemann H., Döring G. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients. Pediatr Pulmonol Mar 2007, 42(3):249-255.
18. da Silva Filho L.V., Tateno A.F., Martins K.M., Azzuz Chernishev A.C., Garcia D.O., Haug M., et al. The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis. Pediatr Pulmonol Oct 2007, 42(10):938-944.
19. Hansen C.R., Pressler T., Høiby N. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. J Cyst Fibros Nov 2008, 7(6):523-530.
20. Bonestroo H.J., de Winter-de Groot K.M., van der Ent C.K., Arets H.G. Upper and lower airway cultures in children with cystic fibrosis: do not neglect the upper airways. J Cyst Fibros Mar 2010, 9(2):130-134.
21. Høiby N., Frederiksen B., Pressler T. Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros Aug 2005, 4(Suppl. 2):49-54.
22. Mainz J.G., Naehrlich L., Schien M., Kading M., Schiller I., Mayr S., et al. Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis. Thorax Jun 2009, 64(6):535-540.
23. Schraven S.P., Wehrmann M., Wagner W., Blumenstock G., Koitschev A. Prevalence and histopathology of chronic polypoid sinusitis in pediatric patients with cystic fibrosis. J Cyst Fibros May 2011, 10(3):181-186.
24. Thomas M., Yawn B.P., Price D., Lund V., Mullol J., Fokkens W. EPOS primary care guidelines: European position paper on the primary care diagnosis and management of rhinosinusitis and nasal polyps. Prim Care Respir J Jun 2008, 17(2):79-89.
25. Johansson M.E., Hansson G.C. Microbiology. Keeping bacteria at a distance. Science Oct 14, 2011, 334(6053):182-183.
26. Kolpen M., Hansen C.R., Bjarnsholt T., Moser C., Christensen L.D., van G.M., et al. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax Jan 2010, 65(1):57-62.
27. Worlitzsch D., Tarran R., Ulrich M., Schwab U., Cekici A., Meyer K.C., et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest Feb 2002, 109(3):317-325.
28. Dingman J.R., Rayner M.G., Mishra S., Zhang Y., Ehrlich M.D., Post J.C., et al. Correlation between presence of viable bacteria and presence of endotoxin in middle-ear effusions. J Clin Microbiol Nov 1998, 36(11):3417-3419.
29. Rayner M.G., Zhang Y., Gorry M.C., Chen Y., Post J.C., Ehrlich G.D. Evidence of bacterial metabolic activity in culture-negative otitis media with effusion. JAMA Jan 28, 1998, 279(4):296-299.
30. Sørensen C.H. Quantitative aspects of the mucosal immunity and bacteriology of the nasopharynx and middle ear cavity. Studies on children with clinically different forms of otitis media. APMIS Suppl 1990, 16:1-41.
31. Kerem E., Conway S., Elborn S., Heijerman H. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros Mar 2005, 4(1):7-26.
32. Mainz J.G., Michl R., Pfister W., Beck J.F. Cystic fibrosis upper airways primary colonization with Pseudomonas aeruginosa: eradicated by sinonasal antibiotic inhalation. Am J Respir Crit Care Med Nov 1, 2011, 184(9):1089-1090.
33. Howarth P.H., Persson C.G., Meltzer E.O., Jacobson M.R., Durham S.R., Silkoff P.E. Objective monitoring of nasal airway inflammation in rhinitis. J Allergy Clin Immunol Mar 2005, 115(3 Suppl 1):S414-S441.